Orphan drug development is not taking off.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 494, doi. 10.1111/j.1365-2125.2009.03369.x
- By:
- Publication type:
- Article
Works matching IS 03065251 AND DT 2009 AND VI 67 AND IP 5
Results: 16
1
2
The impact of clinical trials legislation on clinical pharmacology: problems and solutions.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 487, doi. 10.1111/j.1365-2125.2009.03379.x
- By:
- Publication type:
- Article
3
Determinants of the drug utilization profile in the paediatric population in Italy's Lombardy Region.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 565, doi. 10.1111/j.1365-2125.2009.03380.x
- By:
- Publication type:
- Article
4
Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 511, doi. 10.1111/j.1365-2125.2009.03381.x
- By:
- Publication type:
- Article
5
Electrocardiogram changes and arrhythmias in venlafaxine overdose.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 572, doi. 10.1111/j.1365-2125.2009.03382.x
- By:
- Publication type:
- Article
6
Effects of Schisandra sphenanthera extract on the pharmacokinetics of midazolam in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 541, doi. 10.1111/j.1365-2125.2009.03383.x
- By:
- Publication type:
- Article
7
The pharmacokinetics and pharmacodynamics of warfarin in combination with ambrisentan in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 527, doi. 10.1111/j.1365-2125.2009.03384.x
- By:
- Publication type:
- Article
8
Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 520, doi. 10.1111/j.1365-2125.2009.03385.x
- By:
- Publication type:
- Article
9
Translation Section.
- Published in:
- 2009
- Publication type:
- Other
10
Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 547, doi. 10.1111/j.1365-2125.2009.03391.x
- By:
- Publication type:
- Article
11
Cetirizine-induced anaphylaxis: a rare adverse drug reaction.
- Published in:
- 2009
- By:
- Publication type:
- Letter
12
Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 535, doi. 10.1111/j.1365-2125.2009.03396.x
- By:
- Publication type:
- Article
13
Acute oxcarbazepine overdose in an autistic boy.
- Published in:
- 2009
- By:
- Publication type:
- Letter
14
Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 558, doi. 10.1111/j.1365-2125.2009.03400.x
- By:
- Publication type:
- Article
15
Pharmacokinetic– pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 5, p. 503, doi. 10.1111/j.1365-2125.2009.03393.x
- By:
- Publication type:
- Article
16
Research governance: the Dutch defence.
- Published in:
- 2009
- By:
- Publication type:
- Editorial